Medicine & Life Sciences
Chronic Renal Insufficiency
100%
Prednisolone
97%
Randomized Controlled Trials
97%
Nephrotic Syndrome
96%
Steroids
63%
Cost-Benefit Analysis
61%
Patient Reported Outcome Measures
53%
Respiratory Tract Infections
45%
Glomerular Filtration Rate
43%
Child
43%
Recurrence
33%
Placebos
30%
Quality of Life
28%
Quality-Adjusted Life Years
27%
Cystatin C
24%
Pituitary Dwarfism
24%
Therapeutics
22%
Multimedia
22%
Donepezil
21%
Sudden Hearing Loss
21%
Angiotensin Receptor Antagonists
21%
Non-Randomized Controlled Trials
20%
Kidney
20%
Plasma Exchange
19%
Health Care Outcome Assessment
19%
Albuminuria
18%
Uterine Hemorrhage
18%
Renin-Angiotensin System
18%
Patient Selection
18%
Sensorineural Hearing Loss
18%
Chronic Kidney Failure
18%
Creatinine
17%
Vasculitis
16%
Polyps
16%
Confidence Intervals
16%
Child Health
16%
Angiotensin-Converting Enzyme Inhibitors
15%
Growth Hormone
15%
Hemorrhage
15%
Random Allocation
14%
Glucocorticoids
14%
Costs and Cost Analysis
14%
Hearing
14%
Pediatrics
14%
Immunosuppressive Agents
14%
Longitudinal Studies
13%
Cytoplasm
13%
Outpatients
12%
Inpatients
12%
Disease Progression
12%
Social Sciences
end stage renal disease
24%
inpatient treatment
23%
quality of life
20%
life years
20%
costs
19%
Child health
16%
relapse
15%
evaluation
14%
childhood
13%
economics
13%
death
11%
confidence
10%
management
8%
adverse events
8%
time
8%
Group
7%
health
5%
Healthcare
5%
